BioMendics advances its TAMES-02 trial of TolaSureâ„¢, a potential disease-modifying topical therapy for Epidermolysis Bullosa ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback